SLDE insider unloads 11% stake during IPO share sale

Rhea-AI Filing Summary

Slide Insurance (NYSE:SLDE) filed a Form 4 disclosing that director Beth W. Bruce Witte sold 31,029 common shares on 06/23/2025 at $15.81, generating roughly $0.49 million. The shares were held by the Beth W. Bruce Witte Family 1992 Trust and were sold under an underwriting agreement dated 06/17/2025 in connection with the company’s recent IPO.

Post-transaction, the trust still owns 251,645 shares, leaving Witte with substantial exposure. The sale represents about 11 % of her pre-sale holdings, and no derivative transactions were reported.

Positive

• None.

Negative

• Director sold 31,029 shares (~11% of holdings) at $15.81, potentially signaling reduced confidence post-IPO.

Insights

Corporate Governance Expert

Director sells 11% post-IPO stake; modest negative, but liquidity-driven.

The 31,029-share sale equates to roughly 11% of Witte’s indirect holdings and totals about $0.5 M. Executed through the IPO underwriting agreement, it appears liquidity-motivated rather than a bearish signal. Nonetheless, early insider selling can soften sentiment and enlarge the post-IPO discount. Witte retains a sizeable 251,645-share stake, preserving alignment. Overall impact: slightly negative.

Portfolio Manager

Sale small vs. float; neutral market impact expected.

The dollar value is immaterial relative to expected float, and the price matches the offering level, suggesting no urgency or insider pessimism. Remaining ownership supports continued alignment. Unless additional insider selling follows, this filing should have limited influence on valuation or liquidity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bruce Beth Witte

(Last) (First) (Middle)

C/O SLIDE INSURANCE HOLDINGS, INC.,

4221 W. BOY SCOUT BLVD., SUITE 200

(Street)

TAMPA FL 33607

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/23/2025		S		31,029(1)	D	$15.81(1)	251,645	I	By Beth W. Bruce Witte Family 1992 Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold pursuant to an underwriting agreement dated as of June 17, 2025, by and among the issuer, the selling stockholders and the underwriters named therein in connection with the issuer's initial public offering.

	/s/ Jesse Schalk, Attorney-in-Fact for Beth W. Bruce	06/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Slide Insurance shares did the director sell on June 23, 2025?

She sold 31,029 common shares at $15.81 per share.

What percentage of her holdings does the SLDE director's sale represent?

The transaction equals approximately 11% of her indirect ownership before the sale.

How many SLDE shares does the director still own after the sale?

She retains 251,645 shares indirectly through the family trust.

Was the share sale part of Slide Insurance's IPO agreement?

Yes. The Form 4 states the sale was made under an underwriting agreement dated 06/17/2025 tied to the IPO.

Did the Form 4 report any derivative security transactions for SLDE?

No. Table II shows no derivative securities acquired or disposed of.